Cargando…
维奈克拉联合阿扎胞苷治疗难治复发性急性髓系白血病疗效及安全性分析
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607025/ https://www.ncbi.nlm.nih.gov/pubmed/34788928 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.10.012 |
| _version_ | 1784602466076065792 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8607025 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86070252021-11-22 维奈克拉联合阿扎胞苷治疗难治复发性急性髓系白血病疗效及安全性分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2021-10 /pmc/articles/PMC8607025/ /pubmed/34788928 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.10.012 Text en 2021年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
| spellingShingle | 短篇论著 维奈克拉联合阿扎胞苷治疗难治复发性急性髓系白血病疗效及安全性分析 |
| title | 维奈克拉联合阿扎胞苷治疗难治复发性急性髓系白血病疗效及安全性分析 |
| title_full | 维奈克拉联合阿扎胞苷治疗难治复发性急性髓系白血病疗效及安全性分析 |
| title_fullStr | 维奈克拉联合阿扎胞苷治疗难治复发性急性髓系白血病疗效及安全性分析 |
| title_full_unstemmed | 维奈克拉联合阿扎胞苷治疗难治复发性急性髓系白血病疗效及安全性分析 |
| title_short | 维奈克拉联合阿扎胞苷治疗难治复发性急性髓系白血病疗效及安全性分析 |
| title_sort | 维奈克拉联合阿扎胞苷治疗难治复发性急性髓系白血病疗效及安全性分析 |
| topic | 短篇论著 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607025/ https://www.ncbi.nlm.nih.gov/pubmed/34788928 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.10.012 |
| work_keys_str_mv | AT wéinàikèlāliánhéāzhābāogānzhìliáonánzhìfùfāxìngjíxìngsuǐxìbáixuèbìngliáoxiàojíānquánxìngfēnxī AT wéinàikèlāliánhéāzhābāogānzhìliáonánzhìfùfāxìngjíxìngsuǐxìbáixuèbìngliáoxiàojíānquánxìngfēnxī AT wéinàikèlāliánhéāzhābāogānzhìliáonánzhìfùfāxìngjíxìngsuǐxìbáixuèbìngliáoxiàojíānquánxìngfēnxī AT wéinàikèlāliánhéāzhābāogānzhìliáonánzhìfùfāxìngjíxìngsuǐxìbáixuèbìngliáoxiàojíānquánxìngfēnxī AT wéinàikèlāliánhéāzhābāogānzhìliáonánzhìfùfāxìngjíxìngsuǐxìbáixuèbìngliáoxiàojíānquánxìngfēnxī AT wéinàikèlāliánhéāzhābāogānzhìliáonánzhìfùfāxìngjíxìngsuǐxìbáixuèbìngliáoxiàojíānquánxìngfēnxī AT wéinàikèlāliánhéāzhābāogānzhìliáonánzhìfùfāxìngjíxìngsuǐxìbáixuèbìngliáoxiàojíānquánxìngfēnxī AT wéinàikèlāliánhéāzhābāogānzhìliáonánzhìfùfāxìngjíxìngsuǐxìbáixuèbìngliáoxiàojíānquánxìngfēnxī AT wéinàikèlāliánhéāzhābāogānzhìliáonánzhìfùfāxìngjíxìngsuǐxìbáixuèbìngliáoxiàojíānquánxìngfēnxī AT wéinàikèlāliánhéāzhābāogānzhìliáonánzhìfùfāxìngjíxìngsuǐxìbáixuèbìngliáoxiàojíānquánxìngfēnxī AT wéinàikèlāliánhéāzhābāogānzhìliáonánzhìfùfāxìngjíxìngsuǐxìbáixuèbìngliáoxiàojíānquánxìngfēnxī |